Literature DB >> 32324428

The Potential Health Care Costs And Resource Use Associated With COVID-19 In The United States.

Sarah M Bartsch1, Marie C Ferguson2, James A McKinnell3, Kelly J O'Shea4, Patrick T Wedlock5, Sheryl S Siegmund6, Bruce Y Lee7.   

Abstract

With the coronavirus disease 2019 (COVID-19) pandemic, one of the major concerns is the direct medical cost and resource use burden imposed on the US health care system. We developed a Monte Carlo simulation model that represented the US population and what could happen to each person who got infected. We estimated resource use and direct medical costs per symptomatic infection and at the national level, with various "attack rates" (infection rates), to understand the potential economic benefits of reducing the burden of the disease. A single symptomatic COVID-19 case could incur a median direct medical cost of $3,045 during the course of the infection alone. If 80 percent of the US population were to get infected, the result could be a median of 44.6 million hospitalizations, 10.7 million intensive care unit (ICU) admissions, 6.5 million patients requiring a ventilator, 249.5 million hospital bed days, and $654.0 billion in direct medical costs over the course of the pandemic. If 20 percent of the US population were to get infected, there could be a median of 11.2 million hospitalizations, 2.7 million ICU admissions, 1.6 million patients requiring a ventilator, 62.3 million hospital bed days, and $163.4 billion in direct medical costs over the course of the pandemic.

Entities:  

Keywords:  COVID-19; Coronavirus; Cost reduction; Costs and spending; Diseases; Economic burden; Health policy; Hospital costs; Intensive care units; Prescription drug costs; Value; cost

Mesh:

Year:  2020        PMID: 32324428     DOI: 10.1377/hlthaff.2020.00426

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  81 in total

Review 1.  4'-Fluorouridine Is a Broad-Spectrum Orally Available First-Line Antiviral That May Improve Pandemic Preparedness.

Authors:  Carolin M Lieber; Richard K Plemper
Journal:  DNA Cell Biol       Date:  2022-07-05       Impact factor: 3.550

Review 2.  Pain during and after coronavirus disease 2019: Chinese perspectives.

Authors:  Feng Jiang; Wan-Li Yang; Jia-Wei Wang; Zhen Zhu; Ceng Luo; Lars Arendt-Nielsen; Xue-Jun Song
Journal:  Pain Rep       Date:  2021-05-10

3.  The Impact of COVID-19 on the Latinx Population: A Scoping Literature Review.

Authors:  Karen S Moore
Journal:  Public Health Nurs       Date:  2021-04-20       Impact factor: 1.770

Review 4.  A review of nasopharyngeal swab and saliva tests for SARS-CoV-2 infection: Disease timelines, relative sensitivities, and test optimization.

Authors:  Marylin Roque; Kevin Proudfoot; Vadim Mathys; Sophie Yu; Natalie Krieger; Thomas Gernon; Kash Gokli; Stanley Hamilton; Colin Cook; Yuman Fong
Journal:  J Surg Oncol       Date:  2021-06-06       Impact factor: 2.885

5.  Why some parents made firearms more accessible during the beginning of the COVID-19 pandemic: results from a national study.

Authors:  Rebeccah L Sokol; Lea Marineau; Marc A Zimmerman; Laney A Rupp; Rebecca M Cunningham; Patrick M Carter
Journal:  J Behav Med       Date:  2021-07-23

6.  Thinking green: modelling respirator reuse strategies to reduce cost and waste.

Authors:  Jacqueline Chu; Omkar Ghenand; Joy Collins; James Byrne; Adam Wentworth; Peter R Chai; Farah Dadabhoy; Chin Hur; Giovanni Traverso
Journal:  BMJ Open       Date:  2021-07-18       Impact factor: 2.692

7.  Adherence to COVID-19 Nutrition Guidelines Is Associated with Better Nutritional Management Behaviors of Hospitalized COVID-19 Patients.

Authors:  Amelia Faradina; Sung-Hui Tseng; Dang Khanh Ngan Ho; Esti Nurwanti; Hamam Hadi; Sintha Dewi Purnamasari; Imaning Yulia Rochmah; Jung-Su Chang
Journal:  Nutrients       Date:  2021-06-03       Impact factor: 5.717

8.  Nursing strategic pillars to enhance nursing preparedness and response to COVID-19 pandemic at a tertiary care hospital in Saudi Arabia.

Authors:  Nabeeha Tashkandi; Maha Aljuaid; Theolinda McKerry; John Alchin; Laura Taylor; Elmer J Catangui; Rana Mulla; Suwarnnah Sinnappan; Georges Nammour; Aiman El-Saed; Majid M Alshamrani
Journal:  J Infect Public Health       Date:  2021-07-02       Impact factor: 7.537

9.  Hospitalization Costs of COVID-19 Cases and Their Associated Factors in Guangdong, China: A Cross-Sectional Study.

Authors:  Moran Dong; Zuyao Yang; Yingyao Chen; Jiufeng Sun; Wenjun Ma; Shouzhen Cheng; Xiaoli Sun; Jianpeng Xiao; Guanhao He; Jianxiong Hu; Jiaqi Wang; Guimin Chen; He Zhou; Lixia Yuan; Jiali Li; Xuan Li; Hui Xu; Ruijie Wang; Dengzhou Chen; Ming Fang; Tao Liu
Journal:  Front Med (Lausanne)       Date:  2021-06-11

10.  Comorbidities and Factors Determining Medical Expenses and Length of Stay for Admitted COVID-19 Patients in Korea.

Authors:  Su Yeon Jang; Jeong-Yeon Seon; Seung Heon Lee; In-Hwan Oh; Seok-Jun Yoon; So-Youn Park
Journal:  Risk Manag Healthc Policy       Date:  2021-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.